The results showed that the TCMF significantly alleviated the symptoms of endometritis, reduced epithelial sloughing in the uterus, and significantly lowered the mRNA levels of IL-1β and IL-6 in uterine tissue. The gene discussed is IL6; the disease is endometritis.